Now, new research in the Journal of The American Medical Association suggests this may be overkill.
The study looked at 342 adults with asthma. Patients who only used their inhaler when they had symptoms did just as well as patients who breathed the steroids twice a day, whether they had symptoms or not.
Instead of a one-size-fits-all approach, this indicates that customized treatments and less medication could decrease costs.
